<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2018-01-31" version="217">
<accession>P10721</accession>
<accession>B5A956</accession>
<accession>D5LXN2</accession>
<accession>D5M931</accession>
<accession>F5H8F8</accession>
<accession>Q6IQ28</accession>
<accession>Q99662</accession>
<accession>Q9UM99</accession>
<name>KIT_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mast/stem cell growth factor receptor Kit</fullName>
<shortName>SCFR</shortName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Piebald trait protein</fullName>
<shortName>PBT</shortName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Kit</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase Kit</fullName>
</alternativeName>
<alternativeName>
<fullName>p145 c-kit</fullName>
</alternativeName>
<alternativeName>
<fullName>v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog</fullName>
</alternativeName>
<cdAntigenName>CD117</cdAntigenName>
</protein>
<gene>
<name type="primary">KIT</name>
<name type="synonym">SCFR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="EMBO J." volume="6" first="3341" last="3351">
<title>Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.</title>
<authorList>
<person name="Yarden Y."/>
<person name="Kuang W.-J."/>
<person name="Yang-Feng T."/>
<person name="Coussens L."/>
<person name="Munemitsu S."/>
<person name="Dull T.J."/>
<person name="Chen E."/>
<person name="Schlessinger J."/>
<person name="Francke U."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="2448137"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Fetal brain</tissue>
<tissue>Term placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Oncogene" volume="7" first="2207" last="2217">
<title>Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene.</title>
<authorList>
<person name="Giebel L.B."/>
<person name="Strunk K.M."/>
<person name="Holmes S.A."/>
<person name="Spritz R.A."/>
</authorList>
<dbReference type="PubMed" id="1279499"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Genomics" volume="39" first="216" last="226">
<title>Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes.</title>
<authorList>
<person name="Andre C."/>
<person name="Hampe A."/>
<person name="Lachaume P."/>
<person name="Martin E."/>
<person name="Wang X.P."/>
<person name="Manus V."/>
<person name="Hu W.X."/>
<person name="Galibert F."/>
</authorList>
<dbReference type="PubMed" id="9027509"/>
<dbReference type="DOI" id="10.1006/geno.1996.4482"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Arthritis Res. Ther." volume="10" first="R73" last="R73">
<title>Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.</title>
<authorList>
<person name="Jin P."/>
<person name="Zhang J."/>
<person name="Sumariwalla P.F."/>
<person name="Ni I."/>
<person name="Jorgensen B."/>
<person name="Crawford D."/>
<person name="Phillips S."/>
<person name="Feldmann M."/>
<person name="Shepard H.M."/>
<person name="Paleolog E.M."/>
</authorList>
<dbReference type="PubMed" id="18593464"/>
<dbReference type="DOI" id="10.1186/ar2447"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2010" name="Pediatr. Blood Cancer" volume="55" first="464" last="470">
<title>Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate.</title>
<authorList>
<person name="Neumann I."/>
<person name="Foell J.L."/>
<person name="Bremer M."/>
<person name="Volkmer I."/>
<person name="Korholz D."/>
<person name="Burdach S."/>
<person name="Staege M.S."/>
</authorList>
<dbReference type="PubMed" id="20658618"/>
<dbReference type="DOI" id="10.1002/pbc.22603"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="6">
<citation type="submission" date="2010-03" db="EMBL/GenBank/DDBJ databases">
<title>Sequence of KIT mRNA from all-trans retinoic acid treated neuroblastoma cell lines.</title>
<authorList>
<person name="Staege M.S."/>
<person name="Neumann I."/>
<person name="Volkmer I."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1993" name="Jpn. J. Cancer Res." volume="84" first="1136" last="1144">
<title>Characterization of the promoter region of the human c-kit proto-oncogene.</title>
<authorList>
<person name="Yamamoto K."/>
<person name="Tojo A."/>
<person name="Aoki N."/>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="7506248"/>
<dbReference type="DOI" id="10.1111/j.1349-7006.1993.tb02813.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="21793" last="21802">
<title>Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C.</title>
<authorList>
<person name="Blume-Jensen P."/>
<person name="Ronnstrand L."/>
<person name="Gout I."/>
<person name="Waterfield M.D."/>
<person name="Heldin C.H."/>
</authorList>
<dbReference type="PubMed" id="7520444"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PIK3R1; RAF1 AND MAPK1</scope>
<scope>INTERACTION WITH GRB2; PIK3R1 AND PIK3 CATALYTIC SUBUNIT</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="14192" last="14200">
<title>Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells.</title>
<authorList>
<person name="Blume-Jensen P."/>
<person name="Wernstedt C."/>
<person name="Heldin C.H."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="7539802"/>
<dbReference type="DOI" id="10.1074/jbc.270.23.14192"/>
</citation>
<scope>PHOSPHORYLATION AT SER-741; SER-746; SER-821 AND SER-959</scope>
<scope>ENZYME REGULATION</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>MUTAGENESIS OF SER-741 AND SER-746</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="5915" last="5920">
<title>Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes.</title>
<authorList>
<person name="Price D.J."/>
<person name="Rivnay B."/>
<person name="Fu Y."/>
<person name="Jiang S."/>
<person name="Avraham S."/>
<person name="Avraham H."/>
</authorList>
<dbReference type="PubMed" id="9038210"/>
<dbReference type="DOI" id="10.1074/jbc.272.9.5915"/>
</citation>
<scope>INTERACTION WITH PIK3R1; MATK/CHK; FYN AND SHC1</scope>
<scope>PHOSPHORYLATION AT TYR-568; TYR-570 AND TYR-721</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27450" last="27455">
<title>Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells.</title>
<authorList>
<person name="Linnekin D."/>
<person name="DeBerry C.S."/>
<person name="Mou S."/>
</authorList>
<dbReference type="PubMed" id="9341198"/>
<dbReference type="DOI" id="10.1074/jbc.272.43.27450"/>
</citation>
<scope>INTERACTION WITH LYN</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="2089" last="2099">
<title>SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.</title>
<authorList>
<person name="Kozlowski M."/>
<person name="Larose L."/>
<person name="Lee F."/>
<person name="Le D.M."/>
<person name="Rottapel R."/>
<person name="Siminovitch K.A."/>
</authorList>
<dbReference type="PubMed" id="9528781"/>
<dbReference type="DOI" id="10.1128/MCB.18.4.2089"/>
</citation>
<scope>INTERACTION WITH PTPN6</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF PTPN6</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Biochem. J." volume="341" first="211" last="216">
<title>Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor.</title>
<authorList>
<person name="Thommes K."/>
<person name="Lennartsson J."/>
<person name="Carlberg M."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="10377264"/>
<dbReference type="DOI" id="10.1042/bj3410211"/>
</citation>
<scope>INTERACTION WITH GRB2 AND GRB7</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT TYR-703 AND TYR-936</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Blood" volume="94" first="539" last="549">
<title>The receptor protein tyrosine phosphatase, PTP-RO, is upregulated during megakaryocyte differentiation and is associated with the c-Kit receptor.</title>
<authorList>
<person name="Taniguchi Y."/>
<person name="London R."/>
<person name="Schinkmann K."/>
<person name="Jiang S."/>
<person name="Avraham H."/>
</authorList>
<dbReference type="PubMed" id="10397721"/>
</citation>
<scope>INTERACTION WITH PTPRU</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF PTPRU</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="FEBS Lett." volume="482" first="54" last="58">
<title>The direct association of the multiple PDZ domain containing proteins (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase activity.</title>
<authorList>
<person name="Mancini A."/>
<person name="Koch A."/>
<person name="Stefan M."/>
<person name="Niemann H."/>
<person name="Tamura T."/>
</authorList>
<dbReference type="PubMed" id="11018522"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)02036-6"/>
</citation>
<scope>INTERACTION WITH MPDZ</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-816</scope>
<scope>MUTAGENESIS OF LYS-623</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="13732" last="13738">
<title>Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.</title>
<authorList>
<person name="Liang X."/>
<person name="Wisniewski D."/>
<person name="Strife A."/>
<person name="Shivakrupa R."/>
<person name="Clarkson B."/>
<person name="Resh M.D."/>
</authorList>
<dbReference type="PubMed" id="11825908"/>
<dbReference type="DOI" id="10.1074/jbc.M200277200"/>
</citation>
<scope>INTERACTION WITH LYN; TEC AND DOK1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="Biochem. J." volume="370" first="1033" last="1038">
<title>The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.</title>
<authorList>
<person name="Wollberg P."/>
<person name="Lennartsson J."/>
<person name="Gottfridsson E."/>
<person name="Yoshimura A."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="12444928"/>
<dbReference type="DOI" id="10.1042/BJ20020716"/>
</citation>
<scope>INTERACTION WITH SH2B2/APS</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF SH2B2/APS</scope>
<scope>MUTAGENESIS OF ILE-571 AND LEU-939</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Exp. Cell Res." volume="288" first="110" last="118">
<title>Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk.</title>
<authorList>
<person name="Lennartsson J."/>
<person name="Wernstedt C."/>
<person name="Engstrom U."/>
<person name="Hellman U."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="12878163"/>
<dbReference type="DOI" id="10.1016/S0014-4827(03)00206-4"/>
</citation>
<scope>PHOSPHORYLATION AT SER-891 AND TYR-900</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>INTERACTION WITH CRK AND PIK3R1</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CRK; AKT1 AND MAP KINASES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="9159" last="9166">
<title>Src family kinases are involved in the differential signaling from two splice forms of c-Kit.</title>
<authorList>
<person name="Voytyuk O."/>
<person name="Lennartsson J."/>
<person name="Mogi A."/>
<person name="Caruana G."/>
<person name="Courtneidge S."/>
<person name="Ashman L.K."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="12511554"/>
<dbReference type="DOI" id="10.1074/jbc.M211726200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-130</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Blood" volume="110" first="2593" last="2599">
<title>The tyrosine kinase FES is an essential effector of KITD816V proliferation signal.</title>
<authorList>
<person name="Voisset E."/>
<person name="Lopez S."/>
<person name="Dubreuil P."/>
<person name="De Sepulveda P."/>
</authorList>
<dbReference type="PubMed" id="17595334"/>
<dbReference type="DOI" id="10.1182/blood-2007-02-076471"/>
</citation>
<scope>INTERACTION WITH FES/FPS</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-816</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="Exp. Cell Res." volume="313" first="3935" last="3942">
<title>Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.</title>
<authorList>
<person name="Sun J."/>
<person name="Pedersen M."/>
<person name="Bengtsson S."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="17904548"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2007.08.021"/>
</citation>
<scope>INTERACTION WITH GRB2 AND CBL</scope>
<scope>UBIQUITINATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CBL</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="11039" last="11047">
<title>The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.</title>
<authorList>
<person name="Sun J."/>
<person name="Pedersen M."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="19265199"/>
<dbReference type="DOI" id="10.1074/jbc.M808058200"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF SIGNALING PATHWAYS AND CELL SURVIVAL</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF CBL</scope>
<scope>PHOSPHORYLATION AT TYR-568; TYR-703; TYR-721 AND TYR-936</scope>
<scope>UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-816</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-959</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Hum. Reprod." volume="25" first="2188" last="2202">
<title>Expression of a truncated form of KIT tyrosine kinase in human spermatozoa correlates with sperm DNA integrity.</title>
<authorList>
<person name="Muciaccia B."/>
<person name="Sette C."/>
<person name="Paronetto M.P."/>
<person name="Barchi M."/>
<person name="Pensini S."/>
<person name="D'Agostino A."/>
<person name="Gandini L."/>
<person name="Geremia R."/>
<person name="Stefanini M."/>
<person name="Rossi P."/>
</authorList>
<dbReference type="PubMed" id="20601678"/>
<dbReference type="DOI" id="10.1093/humrep/deq168"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="J. Biochem." volume="147" first="601" last="609">
<title>Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance.</title>
<authorList>
<person name="DiNitto J.P."/>
<person name="Deshmukh G.D."/>
<person name="Zhang Y."/>
<person name="Jacques S.L."/>
<person name="Coli R."/>
<person name="Worrall J.W."/>
<person name="Diehl W."/>
<person name="English J.M."/>
<person name="Wu J.C."/>
</authorList>
<dbReference type="PubMed" id="20147452"/>
<dbReference type="DOI" id="10.1093/jb/mvq015"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-547; TYR-553; TYR-703; TYR-721; TYR-730; TYR-823 AND TYR-900</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF TYR-823</scope>
<scope>CHARACTERIZATION OF VARIANT HIS-816</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="410" first="224" last="228">
<title>Mechanism of activation of human c-KIT kinase by internal tandem duplications of the juxtamembrane domain and point mutations at aspartic acid 816.</title>
<authorList>
<person name="Kim S.Y."/>
<person name="Kang J.J."/>
<person name="Lee H.H."/>
<person name="Kang J.J."/>
<person name="Kim B."/>
<person name="Kim C.G."/>
<person name="Park T.K."/>
<person name="Kang H."/>
</authorList>
<dbReference type="PubMed" id="21640708"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2011.05.111"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBUNIT</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-816</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5956" last="5966">
<title>Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.</title>
<authorList>
<person name="Chaix A."/>
<person name="Lopez S."/>
<person name="Voisset E."/>
<person name="Gros L."/>
<person name="Dubreuil P."/>
<person name="De Sepulveda P."/>
</authorList>
<dbReference type="PubMed" id="21135090"/>
<dbReference type="DOI" id="10.1074/jbc.M110.182642"/>
</citation>
<scope>FUNCTION IN ACTIVATION AND PHOSPHORYLATION OF STAT1; STAT3; STAT5A AND STAT5B</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="337" first="1" last="13">
<title>Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.</title>
<authorList>
<person name="Roskoski R. Jr."/>
</authorList>
<dbReference type="PubMed" id="16129412"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.055"/>
</citation>
<scope>REVIEW ON KIT SIGNALING</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Stem Cells" volume="23" first="16" last="43">
<title>Normal and oncogenic forms of the receptor tyrosine kinase kit.</title>
<authorList>
<person name="Lennartsson J."/>
<person name="Jelacic T."/>
<person name="Linnekin D."/>
<person name="Shivakrupa R."/>
</authorList>
<dbReference type="PubMed" id="15625120"/>
<dbReference type="DOI" id="10.1634/stemcells.2004-0117"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Clin. Cancer Res." volume="14" first="1926" last="1930">
<title>Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway.</title>
<authorList>
<person name="Kent D."/>
<person name="Copley M."/>
<person name="Benz C."/>
<person name="Dykstra B."/>
<person name="Bowie M."/>
<person name="Eaves C."/>
</authorList>
<dbReference type="PubMed" id="18381929"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-07-5134"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="757" last="769">
<title>Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors.</title>
<authorList>
<person name="Pittoni P."/>
<person name="Piconese S."/>
<person name="Tripodo C."/>
<person name="Colombo M.P."/>
</authorList>
<dbReference type="PubMed" id="21057534"/>
<dbReference type="DOI" id="10.1038/onc.2010.494"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="31461" last="31464">
<title>Structure of a c-kit product complex reveals the basis for kinase transactivation.</title>
<authorList>
<person name="Mol C.D."/>
<person name="Lim K.B."/>
<person name="Sridhar V."/>
<person name="Zou H."/>
<person name="Chien E.Y."/>
<person name="Sang B.C."/>
<person name="Nowakowski J."/>
<person name="Kassel D.B."/>
<person name="Cronin C.N."/>
<person name="McRee D.E."/>
</authorList>
<dbReference type="PubMed" id="12824176"/>
<dbReference type="DOI" id="10.1074/jbc.C300186200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 549-931 IN COMPLEX WITH ADP AND MAGNESIUM IONS</scope>
<scope>SUBUNIT</scope>
<scope>PHOSPHORYLATION AT TYR-568 AND TYR-570</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="31655" last="31663">
<title>Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase.</title>
<authorList>
<person name="Mol C.D."/>
<person name="Dougan D.R."/>
<person name="Schneider T.R."/>
<person name="Skene R.J."/>
<person name="Kraus M.L."/>
<person name="Scheibe D.N."/>
<person name="Snell G.P."/>
<person name="Zou H."/>
<person name="Sang B.C."/>
<person name="Wilson K.P."/>
</authorList>
<dbReference type="PubMed" id="15123710"/>
<dbReference type="DOI" id="10.1074/jbc.M403319200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 565-935 IN COMPLEXES WITH INHIBITOR IMATINIB AND PHOSPHATE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Cell" volume="130" first="323" last="334">
<title>Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.</title>
<authorList>
<person name="Yuzawa S."/>
<person name="Opatowsky Y."/>
<person name="Zhang Z."/>
<person name="Mandiyan V."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="17662946"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.05.055"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 1-519 IN COMPLEX WITH KITLG/SCF</scope>
<scope>INTERACTION WITH KITLG/SCF</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF ARG-381 AND GLU-386</scope>
<scope>GLYCOSYLATION AT ASN-130; ASN-283; ASN-293; ASN-300; ASN-320; ASN-352 AND ASN-367</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="1542" last="1547">
<title>KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients.</title>
<authorList>
<person name="Gajiwala K.S."/>
<person name="Wu J.C."/>
<person name="Christensen J."/>
<person name="Deshmukh G.D."/>
<person name="Diehl W."/>
<person name="DiNitto J.P."/>
<person name="English J.M."/>
<person name="Greig M.J."/>
<person name="He Y.A."/>
<person name="Jacques S.L."/>
<person name="Lunney E.A."/>
<person name="McTigue M."/>
<person name="Molina D."/>
<person name="Quenzer T."/>
<person name="Wells P.A."/>
<person name="Yu X."/>
<person name="Zhang Y."/>
<person name="Zou A."/>
<person name="Emmett M.R."/>
<person name="Marshall A.G."/>
<person name="Zhang H.M."/>
<person name="Demetri G.D."/>
</authorList>
<dbReference type="PubMed" id="19164557"/>
<dbReference type="DOI" id="10.1073/pnas.0812413106"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 544-935 IN COMPLEX WITH SUNITINIB</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CHARACTERIZATION OF VARIANTS HIS-816 AND VAL-816</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="480" last="490">
<title>Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.</title>
<authorList>
<person name="Zadjali F."/>
<person name="Pike A.C."/>
<person name="Vesterlund M."/>
<person name="Sun J."/>
<person name="Wu C."/>
<person name="Li S.S."/>
<person name="Ronnstrand L."/>
<person name="Knapp S."/>
<person name="Bullock A.N."/>
<person name="Flores-Morales A."/>
</authorList>
<dbReference type="PubMed" id="21030588"/>
<dbReference type="DOI" id="10.1074/jbc.M110.173526"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 564-574 IN COMPLEX WITH SOCS6</scope>
<scope>PHOSPHORYLATION AT TYR-568</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="89" first="1713" last="1717">
<title>Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.</title>
<authorList>
<person name="Fleischman R.A."/>
</authorList>
<dbReference type="PubMed" id="1376329"/>
<dbReference type="DOI" id="10.1172/JCI115772"/>
</citation>
<scope>VARIANT PBT LYS-583</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1992" name="Am. J. Hum. Genet." volume="50" first="261" last="269">
<title>Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.</title>
<authorList>
<person name="Spritz R.A."/>
<person name="Giebel L.B."/>
<person name="Holmes S.A."/>
</authorList>
<dbReference type="PubMed" id="1370874"/>
</citation>
<scope>VARIANT PBT LEU-584</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="8696" last="8699">
<title>Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.</title>
<authorList>
<person name="Giebel L.B."/>
<person name="Spritz R.A."/>
</authorList>
<dbReference type="PubMed" id="1717985"/>
<dbReference type="DOI" id="10.1073/pnas.88.19.8696"/>
</citation>
<scope>VARIANT PBT ARG-664</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1993" name="J. Clin. Invest." volume="92" first="1736" last="1744">
<title>Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.</title>
<authorList>
<person name="Furitsu T."/>
<person name="Tsujimura T."/>
<person name="Tono T."/>
<person name="Ikeda H."/>
<person name="Kitayama H."/>
<person name="Koshimizu U."/>
<person name="Sugahara H."/>
<person name="Butterfield J.H."/>
<person name="Ashman L.K."/>
<person name="Kanayama Y."/>
<person name="Matsuzawa Y."/>
<person name="Kitamura Y."/>
<person name="Kanakura Y."/>
</authorList>
<dbReference type="PubMed" id="7691885"/>
<dbReference type="DOI" id="10.1172/JCI116761"/>
</citation>
<scope>VARIANT MAST CELL LEUKEMIA VAL-816</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1993" name="J. Invest. Dermatol." volume="101" first="22" last="25">
<title>Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.</title>
<authorList>
<person name="Spritz R.A."/>
<person name="Holmes S.A."/>
<person name="Itin P."/>
<person name="Kuester W."/>
</authorList>
<dbReference type="PubMed" id="7687267"/>
<dbReference type="DOI" id="10.1111/1523-1747.ep12358440"/>
</citation>
<scope>VARIANTS PBT GLY-791 AND VAL-812</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="6" first="343" last="345">
<title>A 12-bp deletion (7818del12) in the c-kit protooncogene in a large Italian kindred with piebaldism.</title>
<authorList>
<person name="Riva P."/>
<person name="Milani N."/>
<person name="Gandolfi P."/>
<person name="Larizza L."/>
</authorList>
<dbReference type="PubMed" id="8680409"/>
<dbReference type="DOI" id="10.1002/humu.1380060409"/>
</citation>
<scope>VARIANT PBT 893-GLU--PRO-896 DEL</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1997" name="Br. J. Haematol." volume="96" first="374" last="376">
<title>A new c-kit mutation in a case of aggressive mast cell disease.</title>
<authorList>
<person name="Pignon J.-M."/>
<person name="Giraudier S."/>
<person name="Duquesnoy P."/>
<person name="Jouault H."/>
<person name="Imbert M."/>
<person name="Vainchenker W."/>
<person name="Vernant J.-P."/>
<person name="Tulliez M."/>
</authorList>
<dbReference type="PubMed" id="9029028"/>
<dbReference type="DOI" id="10.1046/j.1365-2141.1997.d01-2042.x"/>
</citation>
<scope>VARIANT MAST CELL DISEASE GLY-820</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1998" name="Am. J. Med. Genet." volume="75" first="101" last="103">
<title>Piebaldism with deafness: molecular evidence for an expanded syndrome.</title>
<authorList>
<person name="Spritz R.A."/>
<person name="Beighton P."/>
</authorList>
<dbReference type="PubMed" id="9450866"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19980106)75:1&lt;101::AID-AJMG20>3.0.CO;2-P"/>
</citation>
<scope>VARIANT PBT GLY-796</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1998" name="Blood" volume="92" first="701" last="702">
<title>c-kit activating mutations and mast cell proliferation in human leukemia.</title>
<authorList>
<person name="Beghini A."/>
<person name="Larizza L."/>
<person name="Cairoli R."/>
<person name="Morra E."/>
</authorList>
<dbReference type="PubMed" id="9657776"/>
</citation>
<scope>VARIANT ACUTE MYELOID LEUKEMIA TYR-816</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1998" name="J. Invest. Dermatol." volume="111" first="337" last="338">
<title>A novel KIT gene missense mutation in a Japanese family with piebaldism.</title>
<authorList>
<person name="Nomura K."/>
<person name="Hatayama I."/>
<person name="Narita T."/>
<person name="Kaneko T."/>
<person name="Shiraishi M."/>
</authorList>
<dbReference type="PubMed" id="9699740"/>
<dbReference type="DOI" id="10.1046/j.1523-1747.1998.00269.x"/>
</citation>
<scope>VARIANT PBT PRO-847</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1998" name="Nat. Genet." volume="19" first="323" last="324">
<title>Familial gastrointestinal stromal tumours with germline mutation of the KIT gene.</title>
<authorList>
<person name="Nishida T."/>
<person name="Hirota S."/>
<person name="Taniguchi M."/>
<person name="Hashimoto K."/>
<person name="Isozaki K."/>
<person name="Nakamura H."/>
<person name="Kanakura Y."/>
<person name="Tanaka T."/>
<person name="Takabayashi A."/>
<person name="Matsuda H."/>
<person name="Kitamura Y."/>
</authorList>
<dbReference type="PubMed" id="9697690"/>
<dbReference type="DOI" id="10.1038/1209"/>
</citation>
<scope>VARIANT GIST VAL-559 DEL</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1998" name="Science" volume="279" first="577" last="580">
<title>Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.</title>
<authorList>
<person name="Hirota S."/>
<person name="Isozaki K."/>
<person name="Moriyama Y."/>
<person name="Hashimoto K."/>
<person name="Nishida T."/>
<person name="Ishiguro S."/>
<person name="Kawano K."/>
<person name="Hanada M."/>
<person name="Kurata A."/>
<person name="Takeda M."/>
<person name="Muhammad Tunio G."/>
<person name="Matsuzawa Y."/>
<person name="Kanakura Y."/>
<person name="Shinomura Y."/>
<person name="Kitamura Y."/>
</authorList>
<dbReference type="PubMed" id="9438854"/>
<dbReference type="DOI" id="10.1126/science.279.5350.577"/>
</citation>
<scope>VARIANTS GIST ILE-550; 550-LYS--LYS-558 DEL; 551-PRO--VAL-555 DEL; ASP-559 AND 559-VAL-VAL-560 DEL</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1999" name="Am. J. Pathol." volume="154" first="1643" last="1647">
<title>Activating c-kit gene mutations in human germ cell tumors.</title>
<authorList>
<person name="Tian Q."/>
<person name="Frierson H.F. Jr."/>
<person name="Krystal G.W."/>
<person name="Moskaluk C.A."/>
</authorList>
<dbReference type="PubMed" id="10362788"/>
<dbReference type="DOI" id="10.1016/S0002-9440(10)65419-3"/>
</citation>
<scope>VARIANT HIS-816</scope>
<scope>CHARACTERIZATION OF VARIANT HIS-816</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="1609" last="1614">
<title>Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.</title>
<authorList>
<person name="Longley B.J. Jr."/>
<person name="Metcalfe D.D."/>
<person name="Tharp M."/>
<person name="Wang X."/>
<person name="Tyrrell L."/>
<person name="Lu S.-Z."/>
<person name="Heitjan D."/>
<person name="Ma Y."/>
</authorList>
<dbReference type="PubMed" id="9990072"/>
<dbReference type="DOI" id="10.1073/pnas.96.4.1609"/>
</citation>
<scope>VARIANTS MASTOCYTOSIS VAL-816; PHE-816; TYR-816 AND LYS-839</scope>
<scope>CHARACTERIZATION OF VARIANTS MASTOCYTOSIS VAL-816; PHE-816; TYR-816 AND LYS-839</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2000" name="Am. J. Med. Genet." volume="95" first="79" last="81">
<title>Three novel mutations of the proto-oncogene KIT cause human piebaldism.</title>
<authorList>
<person name="Syrris P."/>
<person name="Malik N.M."/>
<person name="Murday V.A."/>
<person name="Patton M.A."/>
<person name="Carter N.D."/>
<person name="Hughes H.E."/>
<person name="Metcalfe K."/>
</authorList>
<dbReference type="PubMed" id="11074500"/>
<dbReference type="DOI" id="10.1002/1096-8628(20001106)95:1&lt;79::AID-AJMG16>3.0.CO;2-4"/>
</citation>
<scope>VARIANTS PBT CYS-584; ARG-601 AND PRO-656</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2001" name="Cancer" volume="92" first="657" last="662">
<title>Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa.</title>
<authorList>
<person name="Beghini A."/>
<person name="Tibiletti M.G."/>
<person name="Roversi G."/>
<person name="Chiaravalli A.M."/>
<person name="Serio G."/>
<person name="Capella C."/>
<person name="Larizza L."/>
</authorList>
<dbReference type="PubMed" id="11505412"/>
<dbReference type="DOI" id="10.1002/1097-0142(20010801)92:3&lt;657::AID-CNCR1367>3.0.CO;2-D"/>
</citation>
<scope>VARIANT GIST ALA-559</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="4271" last="4280">
<title>A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors.</title>
<authorList>
<person name="Chen L.L."/>
<person name="Sabripour M."/>
<person name="Wu E.F."/>
<person name="Prieto V.G."/>
<person name="Fuller G.N."/>
<person name="Frazier M.L."/>
</authorList>
<dbReference type="PubMed" id="15824741"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208587"/>
</citation>
<scope>VARIANT GIST 550-LYS--LYS-558 DEL</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2006" name="Genes Chromosomes Cancer" volume="45" first="42" last="46">
<title>Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults.</title>
<authorList>
<person name="Bignell G."/>
<person name="Smith R."/>
<person name="Hunter C."/>
<person name="Stephens P."/>
<person name="Davies H."/>
<person name="Greenman C."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Edkins S."/>
<person name="Stevens C."/>
<person name="O'meara S."/>
<person name="Parker A."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Brackenbury L."/>
<person name="Buck G."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Edwards K."/>
<person name="Forbes S."/>
<person name="Gorton M."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jones D."/>
<person name="Kosmidou V."/>
<person name="Laman R."/>
<person name="Lugg R."/>
<person name="Menzies A."/>
<person name="Perry J."/>
<person name="Petty R."/>
<person name="Raine K."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Solomon H."/>
<person name="Stephens Y."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb A."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Gillis A.J.M."/>
<person name="Stoop H.J."/>
<person name="van Gurp R.J.H.L.M."/>
<person name="Oosterhuis J.W."/>
<person name="Looijenga L.H.J."/>
<person name="Futreal P.A."/>
<person name="Wooster R."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="16175573"/>
<dbReference type="DOI" id="10.1002/gcc.20265"/>
</citation>
<scope>VARIANTS TYR-816; LYS-822 AND PRO-829</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ILE-532; LEU-541; SER-691; ASN-715; ASN-737; TRP-804; TYR-816; LYS-822 AND PRO-829</scope>
</reference>
<comment type="function">
<text evidence="19 24 25 27 38 40 45 46 48 58">Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KIT signaling is modulated by protein phosphatases, and by rapid internalization and degradation of the receptor. Activated KIT promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1.</text>
</comment>
<comment type="catalytic activity">
<text evidence="16 37 39 46 47">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="30 39 46 48 49">Present in an inactive conformation in the absence of bound ligand. KITLG/SCF binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Activity is down-regulated by PRKCA-mediated phosphorylation on serine residues. Inhibited by imatinib/STI-571 (Gleevec) and sunitinib; these compounds maintain the kinase in an inactive conformation.</text>
</comment>
<comment type="subunit">
<text evidence="12 18 19 20 23 24 26 27 36 37 38 39 44 46 48 54 55 58">Monomer in the absence of bound KITLG/SCF. Homodimer in the presence of bound KITLG/SCF, forming a heterotetramer with two KITLG/SCF molecules. Interacts (via phosphorylated tyrosine residues) with the adapter proteins GRB2 and GRB7 (via SH2 domain), and SH2B2/APS. Interacts (via C-terminus) with MPDZ (via the tenth PDZ domain). Interacts (via phosphorylated tyrosine residues) with PIK3R1 and PIK3 catalytic subunit. Interacts (via phosphorylated tyrosine) with CRK (isoform Crk-II), FYN, SHC1 and MATK/CHK (via SH2 domain). Interacts with LYN and FES/FPS. Interacts (via phosphorylated tyrosine residues) with the protein phosphatases PTPN6/SHP-1 (via SH2 domain), PTPN11/SHP-2 (via SH2 domain) and PTPRU. Interacts with PLCG1. Interacts with DOK1 and TEC. Interacts (KITLG/SCF-bound) with IL1RL1. Interacts with IL1RAP (independent of stimulation with KITLG/SCF). A mast cell-specific KITLG/SCF-induced interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-702336">
<id>O75815</id>
<label>BCAR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-2623522">
<id>Q8WV28</id>
<label>BLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1055635">
<id>P07332</id>
<label>FES</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-740418">
<id>O75791</id>
<label>GRAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-3919324">
<id>Q96JZ2</id>
<label>HSH2D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1379527">
<id>P21583</id>
<label>KITLG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-8026435">
<id>Q8VBX6</id>
<label>Mpdz</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>31</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>31</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1383632">
<id>Q13882</id>
<label>PTK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>29</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-397236">
<id>P35235</id>
<label>Ptpn11</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-7052301">
<id>Q92729</id>
<label>PTPRU</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-7879749">
<id>Q9UQQ2</id>
<label>SH2B3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-3923013">
<id>O14796</id>
<label>SH2D1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-745980">
<id>Q8N5H7</id>
<label>SH2D3C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-727062">
<id>P78314</id>
<label>SH3BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-4402156">
<id>Q15464</id>
<label>SHB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-7256023">
<id>P98077</id>
<label>SHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-79084">
<id>Q92529</id>
<label>SHC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1222854">
<id>Q9H6Q3</id>
<label>SLA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-617737">
<id>O14508</id>
<label>SOCS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-714146">
<id>O14543</id>
<label>SOCS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-3929549">
<id>O14544</id>
<label>SOCS6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-6083058">
<id>Q9ULZ2</id>
<label>STAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-3389814">
<id>Q9HBL0</id>
<label>TNS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-949753">
<id>Q63HR2</id>
<label>TNS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-7877438">
<id>P42681</id>
<label>TXK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1379503"/>
<interactant intactId="EBI-1211276">
<id>P43403</id>
<label>ZAP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Detected in the cytoplasm of spermatozoa, especially in the equatorial and subacrosomal region of the sperm head.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P10721-1</id>
<name>1</name>
<name>GNNK(+)</name>
<name>KitA(+)</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P10721-2</id>
<name>2</name>
<name>GNNK(-)</name>
<name>Kit(+)</name>
<sequence type="described" ref="VSP_038385"/>
</isoform>
<isoform>
<id>P10721-3</id>
<name>3</name>
<name>TR-KIT</name>
<sequence type="described" ref="VSP_041866 VSP_041867"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="42 47">Isoform 1 and isoform 2 are detected in spermatogonia and Leydig cells. Isoform 3 is detected in round spermatids, elongating spermatids and spermatozoa (at protein level). Widely expressed. Detected in the hematopoietic system, the gastrointestinal system, in melanocytes and in germ cells.</text>
</comment>
<comment type="induction">
<text evidence="43">Up-regulated by cis-retinoic acid in neuroblastoma cell lines.</text>
</comment>
<comment type="PTM">
<text evidence="38 40">Ubiquitinated by SOCS6. KIT is rapidly ubiquitinated after autophosphorylation induced by KITLG/SCF binding, leading to internalization and degradation.</text>
</comment>
<comment type="PTM">
<text evidence="18 26 40 41 44 54">Autophosphorylated on tyrosine residues. KITLG/SCF binding enhances autophosphorylation. Isoform 1 shows low levels of tyrosine phosphorylation in the absence of added KITLG/SCF (in vitro). Kinase activity is down-regulated by phosphorylation on serine residues by protein kinase C family members. Phosphorylation at Tyr-568 is required for interaction with PTPN11/SHP-2, CRK (isoform Crk-II) and members of the SRC tyrosine-protein kinase family. Phosphorylation at Tyr-570 is required for interaction with PTPN6/SHP-1. Phosphorylation at Tyr-703, Tyr-823 and Tyr-936 is important for interaction with GRB2. Phosphorylation at Tyr-721 is important for interaction with PIK3R1. Phosphorylation at Tyr-823 and Tyr-936 is important for interaction with GRB7.</text>
</comment>
<comment type="disease" evidence="21 28 29 34 50 52 57 61">
<disease id="DI-02164">
<name>Piebald trait</name>
<acronym>PBT</acronym>
<description>Autosomal dominant genetic developmental abnormality of pigmentation characterized by congenital patches of white skin and hair that lack melanocytes.</description>
<dbReference type="MIM" id="172800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22 31 56 60">
<disease id="DI-01646">
<name>Gastrointestinal stromal tumor</name>
<acronym>GIST</acronym>
<description>Common mesenchymal neoplasms arising in the gastrointestinal tract, most often in the stomach. They are histologically, immunohistochemically, and genetically different from typical leiomyomas, leiomyosarcomas, and schwannomas. Most GISTs are composed of a fairly uniform population of spindle-shaped cells. Some tumors are dominated by epithelioid cells or contain a mixture of spindle and epithelioid morphologies. Primary GISTs in the gastrointestinal tract commonly metastasize in the omentum and mesenteries, often as multiple nodules. However, primary tumors may also occur outside of the gastrointestinal tract, in other intra-abdominal locations, especially in the omentum and mesentery.</description>
<dbReference type="MIM" id="606764"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<disease id="DI-02749">
<name>Testicular germ cell tumor</name>
<acronym>TGCT</acronym>
<description>A common malignancy in males representing 95% of all testicular neoplasms. TGCTs have various pathologic subtypes including: unclassified intratubular germ cell neoplasia, seminoma (including cases with syncytiotrophoblastic cells), spermatocytic seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma.</description>
<dbReference type="MIM" id="273300"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<disease id="DI-01171">
<name>Leukemia, acute myelogenous</name>
<acronym>AML</acronym>
<description>A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.</description>
<dbReference type="MIM" id="601626"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis. Somatic mutations that lead to constitutive activation of KIT are detected in AML patients. These mutations fall into two classes, the most common being in-frame internal tandem duplications of variable length in the juxtamembrane region that disrupt the normal regulation of the kinase activity. Likewise, point mutations in the kinase domain can result in a constitutively activated kinase.</text>
</comment>
<comment type="miscellaneous">
<text>Numerous proteins are phosphorylated in response to KIT signaling, but it is not evident to determine which are directly phosphorylated by KIT under in vivo conditions.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/KITID127.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CD117"/>
<text>CD117 entry</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="https://web.expasy.org/spotlight/back_issues/163/"/>
<text>two's company - Issue 163 of August 2014</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="X06182">
<property type="protein sequence ID" value="CAA29548.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X69301">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69302">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69303">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69304">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69305">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69306">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69307">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69308">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69309">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69310">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69311">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69312">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69313">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69314">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69315">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X69316">
<property type="protein sequence ID" value="CAA49159.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U63834">
<property type="protein sequence ID" value="AAC50968.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U63834">
<property type="protein sequence ID" value="AAC50969.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU826594">
<property type="protein sequence ID" value="ACF47630.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU983671">
<property type="protein sequence ID" value="ADF36702.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HM015525">
<property type="protein sequence ID" value="ADF50068.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HM015526">
<property type="protein sequence ID" value="ADF50069.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304031">
<property type="protein sequence ID" value="BAG64945.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006552">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC092545">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC071593">
<property type="protein sequence ID" value="AAH71593.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S67773">
<property type="protein sequence ID" value="AAB29529.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3496.1">
<molecule id="P10721-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47058.1">
<molecule id="P10721-2"/>
</dbReference>
<dbReference type="PIR" id="S01426">
<property type="entry name" value="TVHUKT"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000213.1">
<molecule id="P10721-1"/>
<property type="nucleotide sequence ID" value="NM_000222.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001087241.1">
<molecule id="P10721-2"/>
<property type="nucleotide sequence ID" value="NM_001093772.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.479754"/>
<dbReference type="PDB" id="1PKG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=549-935"/>
</dbReference>
<dbReference type="PDB" id="1QZJ">
<property type="method" value="Model"/>
<property type="chains" value="A=576-932"/>
</dbReference>
<dbReference type="PDB" id="1QZK">
<property type="method" value="Model"/>
<property type="chains" value="A=576-932"/>
</dbReference>
<dbReference type="PDB" id="1R01">
<property type="method" value="Model"/>
<property type="chains" value="A=576-932"/>
</dbReference>
<dbReference type="PDB" id="1T45">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=547-693, A=754-935"/>
</dbReference>
<dbReference type="PDB" id="1T46">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=565-693, A=754-935"/>
</dbReference>
<dbReference type="PDB" id="2E9W">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=26-514"/>
</dbReference>
<dbReference type="PDB" id="2EC8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-519"/>
</dbReference>
<dbReference type="PDB" id="2IUH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=718-728"/>
</dbReference>
<dbReference type="PDB" id="2VIF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="P=564-574"/>
</dbReference>
<dbReference type="PDB" id="3G0E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=544-693, A=754-935"/>
</dbReference>
<dbReference type="PDB" id="3G0F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=544-693, A/B=754-935"/>
</dbReference>
<dbReference type="PDB" id="4HVS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=551-934"/>
</dbReference>
<dbReference type="PDB" id="4K94">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C=308-518"/>
</dbReference>
<dbReference type="PDB" id="4K9E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="C=308-518"/>
</dbReference>
<dbReference type="PDB" id="4PGZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C=308-518"/>
</dbReference>
<dbReference type="PDB" id="4U0I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=563-693, A=754-935"/>
</dbReference>
<dbReference type="PDBsum" id="1PKG"/>
<dbReference type="PDBsum" id="1QZJ"/>
<dbReference type="PDBsum" id="1QZK"/>
<dbReference type="PDBsum" id="1R01"/>
<dbReference type="PDBsum" id="1T45"/>
<dbReference type="PDBsum" id="1T46"/>
<dbReference type="PDBsum" id="2E9W"/>
<dbReference type="PDBsum" id="2EC8"/>
<dbReference type="PDBsum" id="2IUH"/>
<dbReference type="PDBsum" id="2VIF"/>
<dbReference type="PDBsum" id="3G0E"/>
<dbReference type="PDBsum" id="3G0F"/>
<dbReference type="PDBsum" id="4HVS"/>
<dbReference type="PDBsum" id="4K94"/>
<dbReference type="PDBsum" id="4K9E"/>
<dbReference type="PDBsum" id="4PGZ"/>
<dbReference type="PDBsum" id="4U0I"/>
<dbReference type="ProteinModelPortal" id="P10721"/>
<dbReference type="SMR" id="P10721"/>
<dbReference type="BioGrid" id="110015">
<property type="interactions" value="50"/>
</dbReference>
<dbReference type="DIP" id="DIP-1055N"/>
<dbReference type="IntAct" id="P10721">
<property type="interactions" value="66"/>
</dbReference>
<dbReference type="MINT" id="MINT-146746"/>
<dbReference type="STRING" id="9606.ENSP00000288135"/>
<dbReference type="BindingDB" id="P10721"/>
<dbReference type="ChEMBL" id="CHEMBL1936"/>
<dbReference type="DrugBank" id="DB06080">
<property type="generic name" value="ABT-869"/>
</dbReference>
<dbReference type="DrugBank" id="DB01254">
<property type="generic name" value="Dasatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09078">
<property type="generic name" value="Lenvatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05216">
<property type="generic name" value="MP470"/>
</dbReference>
<dbReference type="DrugBank" id="DB04868">
<property type="generic name" value="Nilotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05913">
<property type="generic name" value="OSI-930"/>
</dbReference>
<dbReference type="DrugBank" id="DB06589">
<property type="generic name" value="Pazopanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01962">
<property type="generic name" value="Phosphonotyrosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01268">
<property type="generic name" value="Sunitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05153">
<property type="generic name" value="XL184"/>
</dbReference>
<dbReference type="DrugBank" id="DB05146">
<property type="generic name" value="XL820"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1805"/>
<dbReference type="iPTMnet" id="P10721"/>
<dbReference type="PhosphoSitePlus" id="P10721"/>
<dbReference type="BioMuta" id="KIT"/>
<dbReference type="DMDM" id="125472"/>
<dbReference type="MaxQB" id="P10721"/>
<dbReference type="PaxDb" id="P10721"/>
<dbReference type="PeptideAtlas" id="P10721"/>
<dbReference type="PRIDE" id="P10721"/>
<dbReference type="DNASU" id="3815"/>
<dbReference type="Ensembl" id="ENST00000288135">
<molecule id="P10721-1"/>
<property type="protein sequence ID" value="ENSP00000288135"/>
<property type="gene ID" value="ENSG00000157404"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000412167">
<molecule id="P10721-2"/>
<property type="protein sequence ID" value="ENSP00000390987"/>
<property type="gene ID" value="ENSG00000157404"/>
</dbReference>
<dbReference type="GeneID" id="3815"/>
<dbReference type="KEGG" id="hsa:3815"/>
<dbReference type="UCSC" id="uc010igr.4">
<molecule id="P10721-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3815"/>
<dbReference type="DisGeNET" id="3815"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000157404.15"/>
<dbReference type="GeneCards" id="KIT"/>
<dbReference type="HGNC" id="HGNC:6342">
<property type="gene designation" value="KIT"/>
</dbReference>
<dbReference type="HPA" id="CAB003288"/>
<dbReference type="HPA" id="CAB068253"/>
<dbReference type="HPA" id="CAB072867"/>
<dbReference type="HPA" id="HPA004471"/>
<dbReference type="HPA" id="HPA073252"/>
<dbReference type="MalaCards" id="KIT"/>
<dbReference type="MIM" id="164920">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="172800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="273300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601626">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606764">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P10721"/>
<dbReference type="OpenTargets" id="ENSG00000157404"/>
<dbReference type="Orphanet" id="98829">
<property type="disease" value="'Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)'"/>
</dbReference>
<dbReference type="Orphanet" id="102724">
<property type="disease" value="'Acute myeloid leukemia with t(8;21)(q22;q22) translocation'"/>
</dbReference>
<dbReference type="Orphanet" id="98834">
<property type="disease" value="Acute myeloblastic leukemia with maturation"/>
</dbReference>
<dbReference type="Orphanet" id="158799">
<property type="disease" value="Aleukemic mast cell leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="280785">
<property type="disease" value="Bullous diffuse cutaneous mastocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="158796">
<property type="disease" value="Classic mast cell leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="79455">
<property type="disease" value="Cutaneous mastocytoma"/>
</dbReference>
<dbReference type="Orphanet" id="44890">
<property type="disease" value="Gastrointestinal stromal tumor"/>
</dbReference>
<dbReference type="Orphanet" id="158778">
<property type="disease" value="Isolated bone marrow mastocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="158793">
<property type="disease" value="Lymphoadenopathic mastocytosis with eosinophilia"/>
</dbReference>
<dbReference type="Orphanet" id="158772">
<property type="disease" value="Nodular urticaria pigmentosa"/>
</dbReference>
<dbReference type="Orphanet" id="2884">
<property type="disease" value="Piebaldism"/>
</dbReference>
<dbReference type="Orphanet" id="158769">
<property type="disease" value="Plaque-form urticaria pigmentosa"/>
</dbReference>
<dbReference type="Orphanet" id="280794">
<property type="disease" value="Pseudoxanthomatous diffuse cutaneous mastocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="158775">
<property type="disease" value="Smouldering systemic mastocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="98849">
<property type="disease" value="Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease"/>
</dbReference>
<dbReference type="Orphanet" id="90389">
<property type="disease" value="Telangiectasia macularis eruptiva perstans"/>
</dbReference>
<dbReference type="Orphanet" id="158766">
<property type="disease" value="Typical urticaria pigmentosa"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30128"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000112008"/>
<dbReference type="HOVERGEN" id="HBG104348"/>
<dbReference type="InParanoid" id="P10721"/>
<dbReference type="KO" id="K05091"/>
<dbReference type="OMA" id="PTFKQIV"/>
<dbReference type="OrthoDB" id="EOG091G01TL"/>
<dbReference type="PhylomeDB" id="P10721"/>
<dbReference type="TreeFam" id="TF325768"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433559">
<property type="pathway name" value="Regulation of KIT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="SignaLink" id="P10721"/>
<dbReference type="SIGNOR" id="P10721"/>
<dbReference type="ChiTaRS" id="KIT">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P10721"/>
<dbReference type="GeneWiki" id="CD117"/>
<dbReference type="GenomeRNAi" id="3815"/>
<dbReference type="PRO" id="PR:P10721"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000157404"/>
<dbReference type="CleanEx" id="HS_KIT"/>
<dbReference type="ExpressionAtlas" id="P10721">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P10721">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0001669">
<property type="term" value="C:acrosomal vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009898">
<property type="term" value="C:cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042629">
<property type="term" value="C:mast cell granule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019955">
<property type="term" value="F:cytokine binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004716">
<property type="term" value="F:signal transducer, downstream of receptor, with protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005020">
<property type="term" value="F:stem cell factor receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031532">
<property type="term" value="P:actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097067">
<property type="term" value="P:cellular response to thyroid hormone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002371">
<property type="term" value="P:dendritic cell cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050910">
<property type="term" value="P:detection of mechanical stimulus involved in sensory perception of sound"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048565">
<property type="term" value="P:digestive tract development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035234">
<property type="term" value="P:ectopic germ cell programmed cell death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035162">
<property type="term" value="P:embryonic hemopoiesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050673">
<property type="term" value="P:epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030218">
<property type="term" value="P:erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038162">
<property type="term" value="P:erythropoietin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038093">
<property type="term" value="P:Fc receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008354">
<property type="term" value="P:germ cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006687">
<property type="term" value="P:glycosphingolipid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035701">
<property type="term" value="P:hematopoietic stem cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002327">
<property type="term" value="P:immature B cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038109">
<property type="term" value="P:Kit signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030032">
<property type="term" value="P:lamellipodium assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002320">
<property type="term" value="P:lymphoid progenitor cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008584">
<property type="term" value="P:male gonad development"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002551">
<property type="term" value="P:mast cell chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032762">
<property type="term" value="P:mast cell cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043303">
<property type="term" value="P:mast cell degranulation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060374">
<property type="term" value="P:mast cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070662">
<property type="term" value="P:mast cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035855">
<property type="term" value="P:megakaryocyte development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097326">
<property type="term" value="P:melanocyte adhesion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030318">
<property type="term" value="P:melanocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097324">
<property type="term" value="P:melanocyte migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002318">
<property type="term" value="P:myeloid progenitor cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043069">
<property type="term" value="P:negative regulation of programmed cell death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001541">
<property type="term" value="P:ovarian follicle development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043473">
<property type="term" value="P:pigmentation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904343">
<property type="term" value="P:positive regulation of colon smooth muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046427">
<property type="term" value="P:positive regulation of JAK-STAT cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048170">
<property type="term" value="P:positive regulation of long-term neuronal synaptic plasticity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045747">
<property type="term" value="P:positive regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010863">
<property type="term" value="P:positive regulation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031274">
<property type="term" value="P:positive regulation of pseudopodium assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0120072">
<property type="term" value="P:positive regulation of pyloric antrum smooth muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904349">
<property type="term" value="P:positive regulation of small intestine smooth muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905065">
<property type="term" value="P:positive regulation of vascular smooth muscle cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904251">
<property type="term" value="P:regulation of bile acid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008360">
<property type="term" value="P:regulation of cell shape"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048070">
<property type="term" value="P:regulation of developmental pigmentation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046686">
<property type="term" value="P:response to cadmium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0048103">
<property type="term" value="P:somatic stem cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035019">
<property type="term" value="P:somatic stem cell population maintenance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007286">
<property type="term" value="P:spermatid development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048863">
<property type="term" value="P:stem cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019827">
<property type="term" value="P:stem cell population maintenance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043586">
<property type="term" value="P:tongue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008542">
<property type="term" value="P:visual learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="5"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR027263">
<property type="entry name" value="SCGF_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001824">
<property type="entry name" value="Tyr_kinase_rcpt_3_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF500951">
<property type="entry name" value="SCGF_recepter"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00240">
<property type="entry name" value="RECEPTOR_TYR_KIN_III"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="13">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="Mast/stem cell growth factor receptor Kit" id="PRO_0000016754">
<location>
<begin position="26"/>
<end position="976"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="13">
<location>
<begin position="26"/>
<end position="524"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="13">
<location>
<begin position="525"/>
<end position="545"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="13">
<location>
<begin position="546"/>
<end position="976"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="27"/>
<end position="112"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="121"/>
<end position="205"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="212"/>
<end position="308"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 4">
<location>
<begin position="317"/>
<end position="410"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 5">
<location>
<begin position="413"/>
<end position="507"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="15">
<location>
<begin position="589"/>
<end position="937"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="596"/>
<end position="603"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="671"/>
<end position="677"/>
</location>
</feature>
<feature type="region of interest" description="Important for interaction with phosphotyrosine-binding proteins">
<location>
<begin position="568"/>
<end position="570"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="15 16">
<location>
<position position="792"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium">
<location>
<position position="568"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium">
<location>
<position position="797"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium">
<location>
<position position="810"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="623"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="796"/>
</location>
</feature>
<feature type="site" description="Important for interaction with phosphotyrosine-binding proteins">
<location>
<position position="936"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="68">
<location>
<position position="547"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="68">
<location>
<position position="553"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26 40 44 54">
<location>
<position position="568"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26 54">
<location>
<position position="570"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18 40 41">
<location>
<position position="703"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="40 41 54">
<location>
<position position="721"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="68">
<location>
<position position="730"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCA" evidence="49">
<location>
<position position="741"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCA" evidence="49">
<location>
<position position="746"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="49">
<location>
<position position="821"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="41">
<location>
<position position="823"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="27">
<location>
<position position="891"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="27 41">
<location>
<position position="900"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18 40">
<location>
<position position="936"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 49">
<location>
<position position="959"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="33 37">
<location>
<position position="130"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="145"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="283"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="293"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="300"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="320"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="352"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="37">
<location>
<position position="367"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="463"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="486"/>
</location>
</feature>
<feature type="disulfide bond" evidence="14 37">
<location>
<begin position="58"/>
<end position="97"/>
</location>
</feature>
<feature type="disulfide bond" evidence="14 37">
<location>
<begin position="136"/>
<end position="186"/>
</location>
</feature>
<feature type="disulfide bond" evidence="14 37">
<location>
<begin position="151"/>
<end position="183"/>
</location>
</feature>
<feature type="disulfide bond" evidence="14 37">
<location>
<begin position="233"/>
<end position="290"/>
</location>
</feature>
<feature type="disulfide bond" evidence="14 37">
<location>
<begin position="428"/>
<end position="491"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041866" evidence="64">
<original>KP</original>
<variation>SL</variation>
<location>
<begin position="412"/>
<end position="413"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041867" evidence="64">
<location>
<begin position="414"/>
<end position="976"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_038385" evidence="63 65 66">
<location>
<begin position="510"/>
<end position="513"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55792975." id="VAR_042021" evidence="35">
<original>V</original>
<variation>I</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3822214." id="VAR_042022" evidence="35">
<original>M</original>
<variation>L</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3822214." id="VAR_061289">
<original>M</original>
<variation>V</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST; somatic mutation." id="VAR_033124" evidence="31 56">
<location>
<begin position="550"/>
<end position="558"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST; somatic mutation." id="VAR_033123" evidence="56">
<original>K</original>
<variation>I</variation>
<location>
<position position="550"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST; somatic mutation." id="VAR_033125" evidence="56">
<location>
<begin position="551"/>
<end position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST; somatic mutation." id="VAR_033128" evidence="56">
<location>
<begin position="559"/>
<end position="560"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST; dbSNP:rs121913517." id="VAR_033126" evidence="22">
<original>V</original>
<variation>A</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST; somatic mutation; dbSNP:rs121913517." id="VAR_033127" evidence="56">
<original>V</original>
<variation>D</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In GIST." id="VAR_007965" evidence="60">
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT; dbSNP:rs121913680." id="VAR_004104" evidence="29">
<original>E</original>
<variation>K</variation>
<location>
<position position="583"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT; dbSNP:rs28933371." id="VAR_033129" evidence="21">
<original>F</original>
<variation>C</variation>
<location>
<position position="584"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT; dbSNP:rs794726671." id="VAR_004105" evidence="28">
<original>F</original>
<variation>L</variation>
<location>
<position position="584"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT." id="VAR_033130" evidence="21">
<original>G</original>
<variation>R</variation>
<location>
<position position="601"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT." id="VAR_033131" evidence="21">
<original>L</original>
<variation>P</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT; dbSNP:rs121913679." id="VAR_004106" evidence="34">
<original>G</original>
<variation>R</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35200131." id="VAR_042023" evidence="35">
<original>C</original>
<variation>S</variation>
<location>
<position position="691"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56094246." id="VAR_042024" evidence="35">
<original>S</original>
<variation>N</variation>
<location>
<position position="715"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs751005114." id="VAR_042025" evidence="35">
<original>D</original>
<variation>N</variation>
<location>
<position position="737"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT." id="VAR_004107" evidence="50">
<original>R</original>
<variation>G</variation>
<location>
<position position="791"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT; with sensorineural deafness; dbSNP:rs121913684." id="VAR_033132" evidence="57">
<original>R</original>
<variation>G</variation>
<location>
<position position="796"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs145602440." id="VAR_042026" evidence="35">
<original>R</original>
<variation>W</variation>
<location>
<position position="804"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT." id="VAR_004108" evidence="50">
<original>G</original>
<variation>V</variation>
<location>
<position position="812"/>
</location>
</feature>
<feature type="sequence variant" description="In mastocytosis; requires 2 nucleotide substitutions; somatic mutation; constitutively activated and is much more rapidly autophosphorylated than wild type." id="VAR_033133" evidence="62">
<original>D</original>
<variation>F</variation>
<location>
<position position="816"/>
</location>
</feature>
<feature type="sequence variant" description="In a testicular tumor; seminoma; somatic mutation; constitutively activated; dbSNP:rs121913506." id="VAR_033134" evidence="17 39 41">
<original>D</original>
<variation>H</variation>
<location>
<position position="816"/>
</location>
</feature>
<feature type="sequence variant" description="In mast cell leukemia and mastocytosis; somatic mutation; constitutively activated; loss of interaction with MPDZ; dbSNP:rs121913507." id="VAR_004109" evidence="20 36 39 40 46 51 62">
<original>D</original>
<variation>V</variation>
<location>
<position position="816"/>
</location>
</feature>
<feature type="sequence variant" description="In acute myeloid leukemia, mastocytosis and a germ cell tumor of the testis; somatic mutation; constitutively activated; dbSNP:rs121913506." id="VAR_023828" evidence="32 35 59 62">
<original>D</original>
<variation>Y</variation>
<location>
<position position="816"/>
</location>
</feature>
<feature type="sequence variant" description="In mast cell disease; systemic; dbSNP:rs121913682." id="VAR_033135" evidence="53">
<original>D</original>
<variation>G</variation>
<location>
<position position="820"/>
</location>
</feature>
<feature type="sequence variant" description="In a germ cell tumor of the testis; somatic mutation; dbSNP:rs121913514." id="VAR_023829" evidence="32 35">
<original>N</original>
<variation>K</variation>
<location>
<position position="822"/>
</location>
</feature>
<feature type="sequence variant" description="In a germ cell tumor of the testis; somatic mutation." id="VAR_023830" evidence="32 35">
<original>A</original>
<variation>P</variation>
<location>
<position position="829"/>
</location>
</feature>
<feature type="sequence variant" description="In mastocytosis; somatic mutation; dominant negative mutation; loss of autophosphorylation; dbSNP:rs121913509." id="VAR_033136" evidence="62">
<original>E</original>
<variation>K</variation>
<location>
<position position="839"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT; dbSNP:rs121913687." id="VAR_033137" evidence="61">
<original>T</original>
<variation>P</variation>
<location>
<position position="847"/>
</location>
</feature>
<feature type="sequence variant" description="In PBT; severe." id="VAR_004110" evidence="52">
<location>
<begin position="893"/>
<end position="896"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces autophosphorylation in response to KITLG/SCF." evidence="37">
<original>R</original>
<variation>A</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces autophosphorylation in response to KITLG/SCF." evidence="37">
<original>E</original>
<variation>A</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduction in SH2B2/APS binding. Abolishes SH2B2/APS binding; when associated with A-939." evidence="24">
<original>I</original>
<variation>A</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="mutagenesis site" description="Stronger interaction with MPDZ." evidence="20">
<original>K</original>
<variation>M</variation>
<location>
<position position="623"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes down-regulation of kinase activity by PKC/PRKCA-mediated phosphorylation; when associated with A-746." evidence="49">
<original>S</original>
<variation>A</variation>
<location>
<position position="741"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes down-regulation of kinase activity by PKC/PRKCA-mediated phosphorylation; when associated with A-741." evidence="49">
<original>S</original>
<variation>A</variation>
<location>
<position position="746"/>
</location>
</feature>
<feature type="mutagenesis site" description="No decrease in activity. Leads to autophosphorylation at Tyr-900." evidence="41">
<original>Y</original>
<variation>F</variation>
<location>
<position position="823"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduction in SH2B2/APS binding. Abolishes SH2B2/APS binding; when associated with A-571." evidence="24">
<original>L</original>
<variation>A</variation>
<location>
<position position="939"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAH71593." ref="9" evidence="67">
<original>L</original>
<variation>I</variation>
<location>
<position position="764"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAH71593." ref="9" evidence="67">
<original>P</original>
<variation>H</variation>
<location>
<position position="838"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="38"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="44"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="54"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="63"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="79"/>
<end position="86"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="93"/>
<end position="99"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="104"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="125"/>
<end position="130"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="132"/>
<end position="134"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="146"/>
<end position="149"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="161"/>
<end position="165"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="169"/>
<end position="174"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="183"/>
<end position="188"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="193"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="213"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="219"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="229"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="243"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="258"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="269"/>
<end position="279"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="286"/>
<end position="293"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="298"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="312"/>
<end position="319"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="321"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="331"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="344"/>
<end position="350"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="356"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="367"/>
<end position="369"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="372"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="388"/>
<end position="395"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="400"/>
<end position="409"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="411"/>
<end position="420"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="425"/>
<end position="434"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="437"/>
<end position="444"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="445"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="452"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="458"/>
<end position="462"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="465"/>
<end position="468"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="472"/>
<end position="479"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="481"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="485"/>
<end position="494"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="499"/>
<end position="506"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="558"/>
<end position="564"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="567"/>
<end position="570"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="573"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="580"/>
<end position="582"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="586"/>
<end position="588"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="589"/>
<end position="597"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="599"/>
<end position="613"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="617"/>
<end position="625"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="631"/>
<end position="647"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="656"/>
<end position="660"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="662"/>
<end position="665"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="667"/>
<end position="671"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="678"/>
<end position="684"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="685"/>
<end position="688"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="719"/>
<end position="721"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="754"/>
<end position="756"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="757"/>
<end position="759"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="760"/>
<end position="762"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="766"/>
<end position="785"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="788"/>
<end position="790"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="795"/>
<end position="797"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="798"/>
<end position="801"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="802"/>
<end position="804"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="805"/>
<end position="808"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="812"/>
<end position="814"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="817"/>
<end position="819"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="823"/>
<end position="825"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="827"/>
<end position="831"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="833"/>
<end position="835"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="838"/>
<end position="843"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="848"/>
<end position="863"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="864"/>
<end position="866"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="877"/>
<end position="885"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="897"/>
<end position="906"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="911"/>
<end position="913"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="917"/>
<end position="930"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="931"/>
<end position="933"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T45"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T46"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2E9W"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2EC8"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IUH"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G0E"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G0F"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HVS"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4K94"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PGZ"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P05532"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255"/>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10362788"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10377264"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10397721"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11018522"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11074500"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11505412"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11825908"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12444928"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12511554"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12824176"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12878163"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1370874"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1376329"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15123710"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15824741"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16175573"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1717985"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17595334"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17662946"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17904548"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19164557"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19265199"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20147452"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20601678"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20658618"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21030588"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21135090"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21640708"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2448137"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7520444"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7539802"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7687267"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7691885"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8680409"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9029028"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9038210"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9341198"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9438854"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9450866"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9528781"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9657776"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9697690"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9699740"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9990072"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18593464"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20658618"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="67" type="ECO:0000305"/>
<evidence key="68" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20147452"/>
</source>
</evidence>
<sequence length="976" mass="109865" checksum="81B0CD76817F3454" modified="1989-07-01" version="1" precursor="true">
MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVGDEIRLLCTD
PGFVKWTFEILDETNENKQNEWITEKAEATNTGKYTCTNKHGLSNSIYVFVRDPAKLFLV
DRSLYGKEDNDTLVRCPLTDPEVTNYSLKGCQGKPLPKDLRFIPDPKAGIMIKSVKRAYH
RLCLHCSVDQEGKSVLSEKFILKVRPAFKAVPVVSVSKASYLLREGEEFTVTCTIKDVSS
SVYSTWKRENSQTKLQEKYNSWHHGDFNYERQATLTISSARVNDSGVFMCYANNTFGSAN
VTTTLEVVDKGFINIFPMINTTVFVNDGENVDLIVEYEAFPKPEHQQWIYMNRTFTDKWE
DYPKSENESNIRYVSELHLTRLKGTEGGTYTFLVSNSDVNAAIAFNVYVNTKPEILTYDR
LVNGMLQCVAAGFPEPTIDWYFCPGTEQRCSASVLPVDVQTLNSSGPPFGKLVVQSSIDS
SAFKHNGTVECKAYNDVGKTSAYFNFAFKGNNKEQIHPHTLFTPLLIGFVIVAGMMCIIV
MILTYKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAF
GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC
TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKQEDHAEAALYKNLLHSKESSCSDSTNE
YMDMKPGVSYVVPTKADKRRSVRIGSYIERDVTPAIMEDDELALDLEDLLSFSYQVAKGM
AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES
IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY
DIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHIYSNLANCSPNRQKPVVDHSVRINSV
GSTASSSQPLLVHDDV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>